Falk Ehmann
Impact in
- Immunology top 10%
- Biosimilars and Bioanalytical Methods
- Pharmacology top 5%
- Pharmacogenetics and Drug Metabolism
Papers in
-
- Health Systems, Economic Evaluations, Quality of Life 6
- Pharmaceutical Economics and Policy 6
- Immunology 10
- Biosimilars and Bioanalytical Methods 10
- Co-authors
- Marisa Papaluca (5 shared papers)Christian K. Schneider (4 shared papers)Iordanis Gravanis (2 shared papers)Camille Vleminckx (3 shared papers)Martina Weise (3 shared papers)Markus Paulmichl (2 shared papers)Marc Maliepaard (2 shared papers)Marisa Papaluca‐Amati (2 shared papers)
- Journals
- Nature Reviews Drug Discovery (4 papers)Frontiers in Medicine (3 papers)British Journal of Clinical Pharmacology (2 papers)Nature Biotechnology (2 papers)Clinical Pharmacology & Therapeutics (2 papers)
- Partner nations
- NetherlandsGermanyUnited Kingdom
In The Last Decade
Falk Ehmann
26 papers receiving 897 citations
Peers
Comparison fields: 5 of 106
- Immunology 383
- Pharmacology 140
- Statistics and Probability 86
- Pediatrics, Perinatology and Child Health 156
- Economics and Econometrics 208
Countries citing papers authored by Falk Ehmann
This map shows the geographic impact of Falk Ehmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Falk Ehmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Falk Ehmann more than expected).
Fields of papers citing papers by Falk Ehmann
This network shows the impact of papers produced by Falk Ehmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Falk Ehmann. The network helps show where Falk Ehmann may publish in the future.
Co-authors
The 25 scholars most cited alongside Falk Ehmann, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 28 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2012 | 273 | |
| 2 | 2013 | 121 | |
| 3 | 2015 | 102 | |
| 4 | 2016 | 75 | |
| 5 | 2012 | 67 | |
| 6 | 2013 | 60 | |
| 7 | 2014 | 35 | |
| 8 | 2022 | 32 | |
| 9 | 2014 | 28 | |
| 10 | 2013 | 28 | |
| 11 | 2021 | 23 | |
| 12 | 2016 | 19 | |
| 13 | 2020 | 19 | |
| 14 | 2022 | 15 | |
| 15 | 2013 | 12 | |
| 16 | 2023 | 8 | |
| 17 | 2015 | 8 | |
| 18 | 2006 | 8 | |
| 19 | 2015 | 6 | |
| 20 | 2025 | 5 |
About Falk Ehmann
Falk Ehmann is a scholar working on Economics and Econometrics, Immunology, Statistics and Probability, Oncology and Pharmacology, having authored 28 papers that have together received 959 indexed citations. Recurring topics across this work include Biosimilars and Bioanalytical Methods (10 papers), Statistical Methods in Clinical Trials (7 papers), Health Systems, Economic Evaluations, Quality of Life (6 papers), Pharmaceutical Economics and Policy (6 papers), Pharmacogenetics and Drug Metabolism (4 papers), Nanoparticle-Based Drug Delivery (3 papers), Nanoparticles: synthesis and applications (3 papers) and Biomedical Ethics and Regulation (3 papers). The work is most often cited by research in Immunology (383 citations), Pharmacology (140 citations), Statistics and Probability (86 citations), Pediatrics, Perinatology and Child Health (156 citations) and Economics and Econometrics (208 citations). Falk Ehmann has collaborated with scholars based in Netherlands, Germany and United Kingdom. Frequent co-authors include Marisa Papaluca, Christian K. Schneider, Iordanis Gravanis, Camille Vleminckx, Martina Weise, Markus Paulmichl, Marc Maliepaard, Marisa Papaluca‐Amati, Niklas Ekman and Esa Heinonen. Their work appears in journals such as Nature Reviews Drug Discovery, Frontiers in Medicine, British Journal of Clinical Pharmacology, Nature Biotechnology and Clinical Pharmacology & Therapeutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.